205 related articles for article (PubMed ID: 23610444)
1. DDB2 suppresses epithelial-to-mesenchymal transition in colon cancer.
Roy N; Bommi PV; Bhat UG; Bhattacharjee S; Elangovan I; Li J; Patra KC; Kopanja D; Blunier A; Benya R; Bagchi S; Raychaudhuri P
Cancer Res; 2013 Jun; 73(12):3771-82. PubMed ID: 23610444
[TBL] [Abstract][Full Text] [Related]
2. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer.
Qin Y; Tang B; Hu CJ; Xiao YF; Xie R; Yong X; Wu YY; Dong H; Yang SM
Oncotarget; 2016 Jan; 7(1):351-61. PubMed ID: 26540342
[TBL] [Abstract][Full Text] [Related]
3. miR-22 and miR-214 targeting BCL9L inhibit proliferation, metastasis, and epithelial-mesenchymal transition by down-regulating Wnt signaling in colon cancer.
Sun R; Liu Z; Han L; Yang Y; Wu F; Jiang Q; Zhang H; Ma R; Miao J; He K; Wang X; Zhou D; Huang C
FASEB J; 2019 Apr; 33(4):5411-5424. PubMed ID: 30698996
[TBL] [Abstract][Full Text] [Related]
4. Dehydropeptidase 1 promotes metastasis through regulation of E-cadherin expression in colon cancer.
Park SY; Lee SJ; Cho HJ; Kim TW; Kim JT; Kim JW; Lee CH; Kim BY; Yeom YI; Lim JS; Lee Y; Lee HG
Oncotarget; 2016 Feb; 7(8):9501-12. PubMed ID: 26824987
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone inhibits hypoxia-induced epithelial-mesenchymal transition in colon cancer.
Kim JH; Hwang YJ; Han SH; Lee YE; Kim S; Kim YJ; Cho JH; Kwon KA; Kim JH; Kim SH
World J Gastroenterol; 2015 Sep; 21(34):9887-99. PubMed ID: 26379394
[TBL] [Abstract][Full Text] [Related]
6. Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer.
Kan JY; Yen MC; Wang JY; Wu DC; Chiu YJ; Ho YW; Kuo PL
Oncotarget; 2016 May; 7(21):31336-49. PubMed ID: 27150059
[TBL] [Abstract][Full Text] [Related]
7. ACTL6A expression promotes invasion, metastasis and epithelial mesenchymal transition of colon cancer.
Zeng Z; Yang H; Xiao S
BMC Cancer; 2018 Oct; 18(1):1020. PubMed ID: 30348114
[TBL] [Abstract][Full Text] [Related]
8. MiR-675-5p supports hypoxia induced epithelial to mesenchymal transition in colon cancer cells.
Costa V; Lo Dico A; Rizzo A; Rajata F; Tripodi M; Alessandro R; Conigliaro A
Oncotarget; 2017 Apr; 8(15):24292-24302. PubMed ID: 28061476
[TBL] [Abstract][Full Text] [Related]
9. Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.
Qi L; Sun B; Liu Z; Cheng R; Li Y; Zhao X
J Exp Clin Cancer Res; 2014 Dec; 33(1):107. PubMed ID: 25499541
[TBL] [Abstract][Full Text] [Related]
10. Ectopic Expression of miR-147 Inhibits Stem Cell Marker and Epithelial-Mesenchymal Transition (EMT)-Related Protein Expression in Colon Cancer Cells.
Ning X; Wang C; Zhang M; Wang K
Oncol Res; 2019 Mar; 27(4):399-406. PubMed ID: 29426374
[TBL] [Abstract][Full Text] [Related]
11. NEDD9 promotes lung cancer metastasis through epithelial-mesenchymal transition.
Jin Y; Li F; Zheng C; Wang Y; Fang Z; Guo C; Wang X; Liu H; Deng L; Li C; Wang H; Chen H; Feng Y; Ji H
Int J Cancer; 2014 May; 134(10):2294-304. PubMed ID: 24174333
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rg3 inhibits epithelial-mesenchymal transition (EMT) and invasion of lung cancer by down-regulating FUT4.
Tian L; Shen D; Li X; Shan X; Wang X; Yan Q; Liu J
Oncotarget; 2016 Jan; 7(2):1619-32. PubMed ID: 26636541
[TBL] [Abstract][Full Text] [Related]
13. IL-32θ inhibits stemness and epithelial-mesenchymal transition of cancer stem cells via the STAT3 pathway in colon cancer.
Bak Y; Kwon T; Bak IS; Hong J; Yu DY; Yoon DY
Oncotarget; 2016 Feb; 7(6):7307-17. PubMed ID: 26824417
[TBL] [Abstract][Full Text] [Related]
14. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.
Li Y; Zhao Z; Xu C; Zhou Z; Zhu Z; You T
Cancer Lett; 2014 Dec; 355(1):130-40. PubMed ID: 25218351
[TBL] [Abstract][Full Text] [Related]
15. HMGA1 induces intestinal polyposis in transgenic mice and drives tumor progression and stem cell properties in colon cancer cells.
Belton A; Gabrovsky A; Bae YK; Reeves R; Iacobuzio-Donahue C; Huso DL; Resar LM
PLoS One; 2012; 7(1):e30034. PubMed ID: 22276142
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional repression of miR-200 family members by Nanog in colon cancer cells induces epithelial-mesenchymal transition (EMT).
Pan Q; Meng L; Ye J; Wei X; Shang Y; Tian Y; He Y; Peng Z; Chen L; Chen W; Bian X; Wang R
Cancer Lett; 2017 Apr; 392():26-38. PubMed ID: 28163188
[TBL] [Abstract][Full Text] [Related]
17. L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers.
Gavert N; Vivanti A; Hazin J; Brabletz T; Ben-Ze'ev A
Mol Cancer Res; 2011 Jan; 9(1):14-24. PubMed ID: 21123622
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA B3GALT5-AS1 suppresses colon cancer liver metastasis via repressing microRNA-203.
Wang L; Wei Z; Wu K; Dai W; Zhang C; Peng J; He Y
Aging (Albany NY); 2018 Dec; 10(12):3662-3682. PubMed ID: 30530918
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of TRPS1 stimulates epithelial-mesenchymal transition and metastasis through repression of FOXA1.
Huang JZ; Chen M; Zeng M; Xu SH; Zou FY; Chen D; Yan GR
J Pathol; 2016 Jun; 239(2):186-96. PubMed ID: 26969828
[TBL] [Abstract][Full Text] [Related]
20. SGK2 is overexpressed in colon cancer and promotes epithelial-mesenchymal transition in colon cancer cells.
Liu Y; Liu J; Kong X; Li H; Shao J; Jiang Z
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1912-1917. PubMed ID: 32565024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
